News

Gary Lamphier: Edmonton's SmileSonica aims to shrink time wearing braces by a third
(November 15, 2016, Edmonton Journal). The small but fast-growing Edmonton-based startup has developed a clinically tested medical device — now approved and commercially available at clinics in 35 countries, including Canada — that shrinks the time required for braces to work by nearly one-third.


New partnership announced between CQDM and the German group AiF to fund new drug development tools

The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany by aligning scientific resources and expertise. This collaborative program gives the opportunity for private and public organizations based in Canada and Germany to develop new expertise and to expand into new markets.

This program is meant to finance the development of novel and potentially transformative next-generation technologies or tools with the potential to improve, enhance or accelerate the state of the art and/or development process. For Canada, the program is focused on biomedical research aimed at developing tools and technologies to improve, accelerate or enhance the drug discovery process. The German funding system is generally technology open. This program is not intended to fund research on new drugs for specific therapeutic segments. This program promotes creativity, innovation, multidisciplinarity and collaborative efforts between academic institutions and private organizations (Small and Medium Enterprises or SMEs) from Canada and Germany.

For detailed information on the program requirements and to view the complete call for proposals for the 2015 competition, please visit: http://www.cqdm.org/en/programs-and-competitions/canada-germany-program.php

 DEADLINE: Canadian applicants must submit an application using the form available on CQDM’s website (www.cqdm.org) no later than January 15th, 2016 at 5 p.m. EST via CQDM’s secured website (https://cqdm.firmex.com/). The content of this proposal must be developed in collaboration between Canadian and German partners


The Canadian Technology Accelerator in France (CTA@FRANCE) is recruiting Health Technology companies!

CTA@FRANCE is a 3 to 4-month program in Paris of the Department of Foreign Affairs, Trade and Development (DFATD), designed to help emerging Canadian health technologies companies to accelerate their business development in France and Europe.

What kind of companies would benefit the most?
Technology driven companies in the medical device and health IT sectors, offering a product or service that addresses a significant medical or health system need in the context of aging populations, and rising healthcare costs.

Opportunities in the following areas:

  • Health analytics to support clinical decision
  • Mobile Health solutions for patient engagement
  • Telehealth solutions for independent living
  • Big data/genomic data/cloud
  • Serious game/simulation/therapeutic education
  • Rehabilitation equipment or software for brain diseases
  • Brain imaging analytic tools
  • Medical devices or digital platforms for neurosurgery

Important Dates
July 1, 2015: Launch of Recruitment
September 25, 2015: Selection of participants completed
November 16, 2015 –March 31,2016: Company Participation
March 2016: Graduation/Exit Interview

For more detailed information and to get connected to the Canadian Trade Commissioner Service in Paris in charge of the program, please contact us.


CANADA - SPAIN 2nd Call for Proposals for Joint R&D Projects 

According to the cooperation agreement between the National Research Council of Canada (NRC) and the Centre for the Development of Industrial Technology of Spain (CDTI), the R&D joint activities between both entities will be performed under the rules and procedures of the multilateral initiative EUREKA, where both countries are members.

Within this framework, participants from both countries are invited to submit joint project proposals for collaborative industry-led R&D projects aimed at creating new products, processes and services for civilian applications.

Phase 1: Expression of Interest will be accepted immediately and up to and including October 16, 2015.
Phase 2: EUREKA Project Applications will be accepted following and approved EOI up to and including November 30, 2015.

This call welcomes applications in all technological areas. However, special priority will be given to proposals of the following domains:

  • Ocean Research
  • Life Sciences
  • ICT to Health
  • Mining Technology
  • Nanomaterials

The Canadian partner should be a SME entity (under the Canadian definition) which may be on technologically and scientifically assisted by a non-industrial entity (eg: university research institute etc). The Spanish and Canadian partners must express their will to cooperate, on an equal basis, to the development of a new product, industrial process or service. The product, process or service must be innovative and there must be a technological risk involved. The project must be equally significant for both participants. Please contact us for more information.

Enterprise Canada Network 
(September 2014) International business opportunities abound on new CME site for all industry sectors Enterprise Canada Network designed to connect Canadian companies with international business opportunities. Canadian Manufacturers & Exporters (CME), in partnership with Export Development Canada (EDC), has launched a website designed to connect Canadian companies with international partners seeking matching products and services. The Enterprise Canada Network is geared towards small- to medium-sized companies, which often face challenges trying to find time to develop business opportunities and not knowing where to look for them. The network will allow businesses and researchers in Canada to search for a business or technology partner amongst the more than 30,000 opportunity profiles posted through the European Commission’s Enterprise Europe Network. 

Health tech startups to get much-needed medicine from new funding portal
(June 19, 2014) Canada’s largest searchable database that connects organizations to more than $30-billion across 7,000 sources of private and government funding is now looking to help health technology startups.

Alberta Diabetes Research Receives a Big Boost
(March 13, 2014) The Alberta Diabetes Institute at the University of Alberta has announced a new collaboration with Janssen Inc. in Canada to advance early-stage technologies related to Type I and Type II diabetes.

Novartis Pharmaceuticals Canada invests $1.2 million in multiple sclerosis research in Alberta
Investment marks first initiative of broader health research collaboration with Alberta government
(November 27, 2013) – Novartis Pharmaceuticals Canada Inc. announced today an investment of $1.2 million in Alberta to collaborate with the Alberta government to advance care and innovation in multiple sclerosis.

Gilead Alberta ULC announces major expansion of research and manufacturing facility in Edmonton, Alberta
(October 21, 2013) Gilead Alberta ULC, a fully integrated research and manufacturing facility of Gilead Sciences Canada Inc., announced a $47 million expansion of its research and manufacturing facility in Edmonton, Alberta.

University of Alberta metabolomics research team collaborates with prestigious BGI Shenzhen, China on new cancer screening technology
(August 12, 2013) A new diagnostic test for pre-cancerous polyps, PolypDx™, from Metabolomic Technologies Inc., is moving towards commercialization thanks to collaboration between the University of Alberta and the renowned BGI Shenzhen (formerly Beijing Genomic Institute).

Alberta and Pfizer build on collaborative research program
(April 24, 2013) The Alberta-Pfizer Translational Research Collaboration is receiving new support from Pfizer and the Alberta government to advance leading-edge health care research towards real-world application. With additional investments from Pfizer of $500,000 and from the Alberta government of $250,000, the Alberta-Pfizer Translational Research Collaboration fund now totals $3.25 million.

Innovative Trauma Care's™ ITClamp Hemorrhage Control System Receives EMS World Top EMS Innovation of 2012 Award
(January 8, 2013)  Innovative Trauma Care, a Canada-based early-stage medical device firm focused on developing point of injury solutions for trauma, first responder and military medicine applications, has been selected as an EMS World 2012 Top EMS Innovations Award winner for the ITClamp Hemorrhage Control System.

Eli Lilly Canada and Alberta Innovates - Health Solutions team up for health research
(July 11, 2012) Getting new drugs or other health care innovations into the hands of doctors and nurses furthers the health of Albertans. And a new research partnership will help develop innovative health care products right here in Alberta.